Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal cancer in humans, with a 5‐year survival rate of <5%. Recently, glypican‐1 (GPC1)‐expressing circulating exosomes were found to be a promising diagnostic tool for PDAC. However, the aberrant expression of GPC1 has not been systematically...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haizhen, Niu, Fangfei, Liu, Fang, Gao, Jiajia, Sun, Yulin, Zhao, Xiaohang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463070/
https://www.ncbi.nlm.nih.gov/pubmed/28440066
http://dx.doi.org/10.1002/cam4.1064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463070/
https://www.ncbi.nlm.nih.gov/pubmed/28440066
http://dx.doi.org/10.1002/cam4.1064

Ejemplares similares